ENTITY
Exelixis Inc

Exelixis Inc (EXEL US)

26
Analysis
Health CareUnited States
Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.
more
Company Event09 Jun 2026 22:40 • Upcoming
Add To Calendar
Company Event28 Jul 2026 05:00 • Upcoming
Add To Calendar
Company Event03 Jun 2026 23:05 • Upcoming
Add To Calendar
Company Event28 May 2026 03:30 • Latest
Company Event27 May 2026 00:00
x